Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	41.13	163.35	115.74
Graham Fair Price	-57.21	9575.13	22377.75
PEG	340.69	-0.27	0.06
Price/Book	7.04	2.20	2.05
Price/Cash Flow	64.84	-3.41	-9.69
Prices/Earnings	515.42	21.81	3.54
Price/Sales	10.53	1.95	1.76
Price/FCF	64.84	-3.41	-9.69
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	34.33	0.06	0.04
Operating Margin	188.81	0.02	< 0.005
ROA	-83.29	< 0.005	0.02
ROE	0.14	0.03	-82.61
ROIC	0.09	< 0.005	-93.11
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.27	0.92	-70.66
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.75	1.87	148.85
EPS QOQ	0.58	-0.80	39.65
FCF QOQ	0.46	-2.12	357.22
Revenue QOQ	0.20	< 0.005	-96.81
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	118.27	124.53	5.29
Days Sales Outstanding (DSO)	111.84	143.06	27.92
Inventory Turnover	0.76	0.72	-5.02
Debt/Capitalization	0.70	0.74	6.24
Quick Ratio	0.64	0.66	2.53
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12396.39	12718.28	2.60
Cash	12080.20	11204.56	-7.25
Capex	-336.96	-854.23	-153.51
Free Cash Flow	-2625.40	-8201.06	-212.37
Revenue	14427.78	14336.12	-0.64
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.23	1.21	-1.86
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	47.28	79.19	67.50
Naive Interpretation	Member

06 - Financial Health · Weak

Rating